Drug Type Small molecule drug |
Synonyms ROR-beta antagonists (Orphagen) |
Target |
Action antagonists |
Mechanism RORB antagonists(RAR related orphan receptor B antagonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | Sweden | 02 Jul 2024 | |
Small Cell Lung Cancer | Preclinical | United States | 02 Jul 2024 | |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Discovery | United States | 01 Apr 2025 |